Flook et al. [117] found MD and VM patients had different pro-inflammatory signatures, a cytokine panel, including IL-1β, and CXC-subfamily chemokines (CCL3, CCL22, CXCL1). This evidence concerns the gene CCL22 and Menkes disease.